These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6688705)

  • 21. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands.
    Brumbaugh PF; Hughes MR; Haussler MR
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4871-5. PubMed ID: 1061076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype.
    Gacad MA; Adams JS
    Endocrinology; 1992 Dec; 131(6):2581-7. PubMed ID: 1446602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties and compartmentalization of the testicular receptor for 1,25-dihydroxyvitamin D3.
    Levy FO; Eikvar L; Jutte NH; Frøysa A; Tvermyr SM; Hansson V
    J Steroid Biochem; 1985 Apr; 22(4):453-60. PubMed ID: 2987614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.
    Giuliano AR; Franceschi RT; Wood RJ
    Arch Biochem Biophys; 1991 Mar; 285(2):261-9. PubMed ID: 1654769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
    Costa EM; Hirst MA; Feldman D
    Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes.
    Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K
    Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus.
    Kato A; Bishop JE; Norman AW
    Biochem Biophys Res Commun; 1998 Mar; 244(3):724-7. PubMed ID: 9535732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N; Dutta A; Ray R
    Biochemistry; 1997 Jun; 36(24):7432-6. PubMed ID: 9200691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.
    Miller GJ; Stapleton GE; Ferrara JA; Lucia MS; Pfister S; Hedlund TE; Upadhya P
    Cancer Res; 1992 Feb; 52(3):515-20. PubMed ID: 1370648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a 1,25-dihydroxy-vitamin D3 receptor in FRTL-5 cells. Evidence for an inhibitory effect of 1,25-dihydroxy-vitamin D3 on thyrotropin-induced iodide uptake.
    Lamberg-Allardt C; Valtonen E; Polojärvi M; Stewen P
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):25-31. PubMed ID: 1665829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor for 1,25-dihydroxyvitamin D3 in GH3 pituitary cells.
    Haussler MR; Manolagas SC; Deftos LJ
    J Steroid Biochem; 1982 Jan; 16(1):15-9. PubMed ID: 6278224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
    Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S; Donaldson CA; Haussler MR
    Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of endogenously occupied and unoccupied binding sites for 1,25-dihydroxyvitamin D3 in rat intestine.
    Massaro ER; Simpson RU; DeLuca HF
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2549-53. PubMed ID: 6302695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells.
    Costa EM; Blau HM; Feldman D
    Endocrinology; 1986 Nov; 119(5):2214-20. PubMed ID: 3021437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration and characterization of a 1 alpha,25-(OH)2D3 receptor-like macromolecule in cultured rat pituitary cells.
    Haug E; Gautvik KM
    J Steroid Biochem; 1985 Nov; 23(5A):625-35. PubMed ID: 3001410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
    Lemay J; Gascon-Barré M
    Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor.
    Colston K; Wilkinson JR; Coombes RC
    Endocrinology; 1986 Jul; 119(1):397-403. PubMed ID: 3013595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.